1:40 pm-1:50 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Davide Capodanno |
Lecturer |
A Preview and Rationale for Ongoing and Future TAVR Clinical Trials |
1:55 pm-2:05 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Ron Waksman |
Lecturer |
New Clinical Indications 1: Valve-in-Valve for Bioprosthetic Valve Failure |
2:05 pm-2:15 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Hasan Jilaihawi |
Lecturer |
New Clinical Indications 2: Bicuspid Aortic Valve Disease |
2:15 pm-2:25 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Martin B. Leon |
Lecturer |
New Clinical Indications 3: The Case for Treating Severe Asymptomatic AS (EARLY TAVR) |
2:25 pm-2:35 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Martin B. Leon |
Lecturer |
New Clinical Indications 4: The Case for Treating Moderate AS and Heart Failure (TAVR UNLOAD) |
2:40 pm-2:55 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Eberhard Grube |
Lecturer |
Featured Lecture: TAVR in Lower Risk Patients |
3:00 pm-3:15 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
John P. Cheatham |
Lecturer |
Transcatheter Pulmonary Valve Implantation: From Melody to PT-Valve |
3:30 pm-5:00 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Eberhard Grube |
Moderator |
|
3:30 pm-5:00 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Nicolo Piazza |
Moderator |
|
3:30 pm-5:00 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Mao Chen |
Moderator |
|
3:30 pm-5:00 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Ran Kornowski |
Discussant |
|
3:30 pm-5:00 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Jan Kovac |
Discussant |
|
3:30 pm-5:00 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Raj Makkar |
Discussant |
|
3:30 pm-5:00 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Andreas Baumbach |
Discussant |
|
3:30 pm-5:00 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
David Hildick-Smith |
Discussant |
|
3:30 pm-3:40 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Andreas Baumbach |
Lecturer |
Controversy #1: Stroke Concerns after TAVR and the Need for Cerebral Embolic Protection |
3:43 pm-3:53 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
David Hildick-Smith |
Lecturer |
Controversy #2: Para-valvular Leak after TAVR - Incidence, Diagnosis and Management Algorithms |
3:56 pm-4:06 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Raj Makkar |
Lecturer |
Controversy #3: The Importance of Valve Leaflet Thickening and Thrombosis after TAVR |
4:09 pm-4:19 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Raj Makkar |
Lecturer |
Controversy #4: TAVR Access Site Alternatives - When Trans-Femoral Isn’t an Option |
4:22 pm-4:32 pm,
Thursday, March 30, 2017
|
Room 311A, Level 3 |
Scientific Symposia
Transcatheter Valve Therapies Part I
|
Eberhard Grube |
Lecturer |
Controversy #5: The Preferred “Minimalist” Strategy for TAVR - Advantages and Limitations |
|
Records:188 Pre[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
Next |
